Related by context. All words. (Click for frequent words.) 74 HIV maturation inhibition 73 TRIOLEX HE# 71 TBC# 67 TRIOLEX ™ 67 ionotropic glutamate receptor antagonists 65 platinum chemotherapeutic 65 PORxin TM platforms 65 R#/MEM # 65 HepDirect R 64 Zemiva TM 64 TOCOSOL Camptothecin 64 Solazed TM 64 metaglidasen 64 generation URAT1 inhibitor 63 muscarinic receptor agonists 63 maturation inhibition 63 Azedra TM 63 immunotherapeutic approaches 63 APOPTONE TM HE# 63 rxRNA 62 PORxin TM 62 Archexin 62 leading oral taxane 62 Zemiva TM Trofex TM 62 Empatic ™ 62 mitochondrial inhibitor 62 THR beta agonist 62 next generation URAT1 62 BHT DNA 62 Oral NKTR 62 oncolytic virus therapies 62 Anticalins R 62 ELND-#/AZD-# 61 selective androgen receptor modulator 61 therapeutic monoclonal antibody 61 Tarmogen 61 EVIZON TM squalamine lactate 61 muscarinic receptor agonist 61 BCR ABL inhibitors 61 sapacitabine CYC# 61 delivers fluocinolone acetonide FA 61 ALN PCS 61 epothilone 61 oral proteasome inhibitor 61 CCX# 61 CD# CEA 61 Trofex TM 61 oral ghrelin agonist 60 CCR9 antagonist 60 including eniluracil ADH 60 candidate CRLX# 60 HuCAL antibodies 60 MKC# 60 MAXY VII 60 AEG# 60 INxin TM 60 product platforms AZX# 60 clinical trials Archexin 60 GPR# agonist 60 Alfacell proprietary ribonuclease 60 PDE4 inhibitor 60 XmAb 60 TELINTRA R 60 PDX pralatrexate novel 60 Ostabolin C TM 60 Pimavanserin 60 candidate REP# 60 SinuNase ™ 60 ALN TTR# 60 dextofisopam 60 IMPDH inhibitor 60 renin inhibitors 60 selective androgen receptor modulators 59 TKM ApoB 59 solid tumors ZYBRESTAT 59 targeted radiotherapeutic 59 commercialize CorMedix drug 59 PNP inhibitor 59 inflammatory autoimmune diseases 59 Iluvien ® 59 MKC# MT 59 mGluR2 NAM 59 EHT AGN 59 novel L DOS# 59 XL# anticancer compounds 59 Transdel TM 59 kidney urologic 59 Nektar proprietary 59 DOS# 59 HEPLISAV TM hepatitis B 59 KNS # 59 rheumatoid arthritis thrombocytopenia 59 IMiDs R 59 ENMD # 59 Elagolix 59 Intermezzo ® zolpidem tartrate 59 proprietary Isolagen Process 59 ONCONASE R 59 HuMax CD#b 59 selective immunoproteasome inhibitor 59 stage antibody MT# 59 Prodarsan R 59 Curaxin 59 Nanobody R 59 LNP formulations 59 Panzem R 59 CORT # 59 XL# XL# XL# XL# 59 INxin 59 maturation inhibitors 59 Ferring Pharmaceuticals specializes 58 polysaccharide polymer 58 Nanobody 58 SILENOR TM doxepin HCl 58 potentially treat nephropathic 58 VitiGam 58 smallpox vaccine IMVAMUNE R 58 include GALNS N 58 Spiegelmer ® 58 modified glutathione analog 58 AdhTAP 58 HQK 58 Canvaxin TM 58 PGL# 58 Apo AIMilano 58 proprietary PharmacoSurgery ™ 58 Neo Kidney Augment 58 ostarine 58 accumulate preferentially 58 highly selective endothelin 58 ART# 58 Adnectin 58 IMiDs ® 58 HE# [002] 58 EyeGate 58 therapeutic monoclonal antibodies 58 Myocet 58 pipeline GlycoPEG GCSF 58 Empatic TM 58 PDE# inhibitors 58 M# rationally 58 ALN VSP 58 Pentad TM 58 acetylgalactosamine 6 58 L Annamycin 58 HepeX B TM 58 HuCNS SC ® 58 REMOXY POSIDUR ELADUR 58 Selective Electrochemical Tumor Ablation 58 oral prodrug 58 RH1 targeted chemotherapeutic agent 58 Angiocept 58 cancer indications bafetinib 58 Synavive ™ 58 thrombin component 58 orally bioavailable mimics 58 Ozarelix 58 taxane derivative 58 Solazed 58 novel nucleoside analog 58 myasthenia gravis Huntington 58 siRNA therapeutic 58 Kosan dependence 58 oral gallium 58 aldehyde dehydrogenase ALDH2 deficiency 58 indications Cytokinetics 58 Sangamo ZFP TF 58 delta opioid receptor 58 Zoraxel TM 58 Aurexis 58 therapeutic peptide 57 Vicriviroc 57 Generx TM 57 PANVAC VF 57 Aganocide ® 57 TKM PLK1 57 MKC# MKC# PP 57 forodesine hydrochloride 57 ZFP Therapeutics 57 CCR2 antagonists 57 Prednisporin 57 antimitotic 57 Panzem R NCD 57 proprietary BiTE ® 57 CYT# vascular disrupting 57 LentiVector technology 57 Proellex TM 57 adrenergic regulation 57 proprietary BiTE R 57 DGAT1 inhibitors 57 ALS #-# 57 oral picoplatin 57 OvaRex R 57 beta islets 57 technology visit www.energyconnectinc.com 57 molecular imaging radiopharmaceutical 57 AN# novel 57 Eg5 kinesin spindle 57 PSN# [002] 57 Charlesson 57 VersaFilm 57 nucleoside tide 57 Dyax phage display 57 GATTEX teduglutide 57 QTinno TM 57 SinuNase TM novel 57 recombinant protective 57 dimebon latrepirdine 57 VitiGam TM 57 HuMax TAC 57 Exelixis compounds 57 OvaRex ® MAb 57 romazarit 57 RADCOM specializes 57 Alexza Staccato 57 Prodarsan ® 57 MCSP respectively 57 recombinant biopharmaceutical 57 APOPTONE ™ 57 pharmacogenomic translational research 57 PORxin 57 oral talactoferrin 57 RapidResponse TM DNA 57 TKB# 57 synthetic anti infective 57 Neo Urinary Conduit 57 mertansine 57 Alocrest 57 antigen rPA anthrax 57 tiapamil 57 fusion enhancers 57 RapidBlue TM 57 Acetavance TM intravenous acetaminophen 57 ImmunoGen TAP technology 57 XmAb ® 57 DXL# 56 SEQureDx ™ 56 either acutely decompensated 56 AAG geldanamycin analog 56 Personalized Immunotherapy 56 generation FBPase inhibitor 56 IMA# 56 Spiegelmer 56 NOX E# 56 therapeutic mAbs 56 Factor VIIa 56 RONDEL ™ 56 tubulin inhibitor 56 HIV RDEA# 56 lipid nanoparticle 56 MEK inhibitors 56 proprietary MSCRAMM protein 56 cancer immunotherapies 56 biobetter 56 DNA RNA Medicines 56 TRAIL receptor antibodies 56 seliciclib CYC# 56 MAP# 56 CYT# potent vascular disrupting 56 Vicor anticipates 56 glucokinase activator 56 Prednisporin TM 56 bioengineered novel 56 overactive bladder AA# 56 Onalta ™ 56 SAR# [002] 56 Intravenous CP 56 cannabinor 56 romidepsin novel 56 topical dermatology 56 platforms GVAX 56 XL# XL# 56 JAK inhibitors 56 Veronate R 56 Anavex #-# 56 AKT inhibitor 56 Surfaxin LS 56 davalintide 56 commercialize deforolimus ARIAD 56 CORT # estimates 56 PSN# [001] 56 Phase 2a clinical trials 56 sulfonylurea glimepiride 56 VIAdel TM technology 56 EP #R 56 candidates Azedra TM 56 preclinically 56 neurodegenerative diseases Alzheimer disease 56 Marqibo TM 56 CRLX# 56 candidate ATHX 56 SILENOR 56 Cardium Therapeutics TM 56 Nanobodies ® 56 Chimigen TM 56 sapropterin dihydrochloride Phase 56 pipeline ImmunoGen collaborators 56 doxepin HCl 56 vii Cubist ability 56 MediGene focuses 56 motexafin gadolinium Injection 56 Relivar 56 proprietary PharmacoSurgery TM 55 GRN# 55 sodium glucose transporter 55 selective GR 55 molecular chaperone regulation 55 VIAdel ™ technology 55 lead molecular radiotherapeutic 55 Nasulin ™ 55 ALK inhibitors 55 TRIOLEX HE# APOPTONE HE# 55 Cardio Vascu Grow 55 Annamycin 55 HIV integrase inhibitors 55 Inc. OTCBB MIVT 55 systemic RNAi therapeutic 55 Novolimus 55 Trofex 55 Mipomersen 55 Raptor preclinical 55 MultiStat 55 ChronVac C R 55 topical antifungal product 55 BioLineRx advances 55 RhuDex ® 55 PEGylated interferon 55 Nanobody ® 55 PEGylation technology 55 TRANSDUR ® 55 polymer conjugate technology 55 behavioral neurobiology 55 beta secretase inhibitors 55 POWERSTACK tm MC# 55 Urocortin 2 55 Aganocide 55 Dr. Marlies Sproll 55 SuperAntibody 55 topically applied SEPA 55 EndoTAG TM 55 CEQ# 55 Protexia ® 55 MEK inhibitor 55 NNR Therapeutics 55 ATD TM Advanced Transdermal 55 GlycoPEGylation TM technologies 55 PREOS R 55 OMP #M# 55 Diamyd ® 55 Panzem 55 Onalta 55 predictive toxicology 55 Pertuzumab 55 Micromet proprietary BiTE 55 vigabatrin GABA aminotransferase inhibitor 55 PHX# 55 NTDDS 55 TG# [003] 55 rusalatide acetate 55 HepeX B 55 incyclinide 55 phase IIa clinical 55 sirtuin modulators 55 Auxilium transmucosal film 55 Neo Kidney Augment ™ 55 UVIDEM 55 non nucleoside HCV 55 OnDose TM 55 ospemifene 55 bioactive carbohydrates 55 intranasal insulin product 55 AdVac ® 55 drug pipeline TAFA# 55 Tekmira SNALP technology 55 bucindolol hydrochloride 55 Maxy G# 55 Cardioxyl 55 MSCRAMM ® 55 INT# [002] 55 prostate cancer antigen prostatic 55 HepDirect 55 Azedra 55 pharmacological chaperone 55 Dyax logo 55 Accelerated Intelligent 55 Nanobodies 55 LHRH antagonists 55 Nasdaq PANC biotechnology 55 cathepsin K inhibitor 55 Bioral Amphotericin B. 55 Veronate 55 anti amnesic 54 Affilin ® 54 TRO# 54 treats acute lymphoblastic 54 active cellular immunotherapy 54 PDE4 modulators 54 CollaFix ™ 54 molecular imaging radiopharmaceuticals 54 TRANSDUR ™ 54 HCV protease inhibitors 54 Telatinib 54 Isis antisense 54 EndoTAG TM -1 54 ASONEP TM 54 SNALP formulation 54 radiation sensitizer 54 Onconase 54 liposomal formulation 54 synthetic cannabinoid library 54 ThermaVolt 54 Delafloxacin 54 Pagoclone 54 Cx# [002] 54 DNA methylation biomarkers 54 delivered RNAi therapeutic 54 Etubics 54 tolevamer 54 Transdel ™ 54 agonistic human 54 compound KOS 54 transmucosal film 54 investigational pharmacologically unique 54 Alnylam dependence 54 investigational monoclonal antibody 54 generation PNP inhibitor 54 HuLuc# 54 androgen receptor antagonist 54 BioMAP Systems 54 urocortin 2 54 IAP inhibitors 54 Alnylam #x# 54 Shigamabs R 54 prostone 54 ReN# 54 ErbB3 HER3 54 bardoxolone 54 ATL/TV# 54 IND enabling 54 generation purine nucleoside 54 Inotek Pharmaceuticals Corporation 54 anticancer therapeutics 54 DepoVax ™ 54 Anticalins 54 ALN TTR 54 CytRx oncology 54 HCV protease inhibitor 54 gastro intestinal inflammation 54 Sym# 54 Tesetaxel 54 BioMAP ® Systems 54 generation NEUGENE antisense 54 QuatRx 54 Technosphere Insulin 54 OMP #R# 54 PEG SN# 54 HuCAL antibody 54 volociximab 54 Symadex 54 clinical trials dacetuzumab SGN 54 synthetic retinoid 54 APC Targeting Technology 54 DsiRNA 54 SLx 54 CB2 selective 54 alvespimycin 54 drug GLPG# 54 nucleotide analog 54 lintuzumab SGN 54 HCV antiviral 54 concerning CombinatoRx 54 MassARRAY ® 54 JAK inhibitor 54 NeuVax 54 Endotis 54 Smac mimetic 54 midstage clinical 54 Memryte 54 diabetes irritable bowel 54 Xcytrin R 54 targeting PCSK9 54 erlotinib Tarceva R 54 Nventa proprietary CoVal 54 Mesafem 54 LEX System 54 RGB # 54 orally administered inhibitor 54 BCX# 54 XOMA 3AB 54 protective antigen rPA 54 Nasulin TM 54 Idera Pharmaceuticals develops 54 Epigenomics proprietary 54 ASONEP ™ 54 HCV NS5B polymerase 54 ATL# [002] 54 Tβ4 synthetic copy 54 Pancreate 54 Vaxfectin TM 54 oral PTH 54 mSEPT9 biomarker 54 Fleximer 54 selective HDAC inhibitors 54 synthetic siRNA 54 LHRH antagonist 54 pan HDAC inhibitor 54 potent suppressor 53 nebulized budesonide 53 INCB# [001] 53 using VIAdel TM 53 XmAb TM 53 unique PER.C6 53 Dapagliflozin 53 Thalomid R 53 HEPLISAV ™ 53 MSCRAMM R 53 ocular formulation 53 anticancer compound 53 SERMs 53 activate SIRT1 53 stranded LNA 53 PRX # 53 HuMax 53 OXIGON TM 53 Apoptone 53 CERA Continuous Erythropoiesis Receptor 53 BEMA TM Fentanyl 53 Omthera 53 CMV vaccine 53 proprietary attenuated Listeria 53 YONDELIS R 53 orally bioavailable 53 immunotherapeutics 53 Anticalin R 53 isoform selective 53 antisense drug 53 EGS# 53 proprietary Customized Linker 53 MassARRAY R 53 histrelin manufacturing marketing 53 Eye Cubed 53 Sphingomab 53 Epanova 53 Ponch Hoe 53 hypoxia activated prodrug 53 anti CD3 monoclonal 53 YONDELIS 53 novel immunomodulatory 53 alagebrium 53 boron chemistry 53 AVAX AC Vaccine 53 TLR9 agonist 53 var arrUrl = 53 demonstrated anti amnesic 53 LymphoStat B TM 53 stable nucleic acid 53 RLY# 53 Pepducin 53 apricitabine ATC 53 PRT# 53 XmAb ™ 53 preclinical compounds 53 Elestrin ® 53 Onco TCS 53 ghrelin antagonist 53 DXL ™ 53 DepoVax TM 53 orally dosed 53 ATRA IV 53 Fc fusion protein 53 elotuzumab 53 DiLA2 53 UltiMAb 53 Trubion proprietary 53 Albugon 53 Shigamabs ® 53 TLR agonists 53 Lixivaptan 53 TPI ASM8 53 vinorelbine tartrate 53 inhibit metastasis 53 bevirimat clinical 53 adipiplon 53 proprietary MSCRAMM ® 53 Guanilib 53 EDEMA3 53 forodesine 53 IoGen ™ 53 radiotherapeutic 53 siRNA therapeutics 53 Chimigen 53 angina nausea 53 polymerase inhibitor 53 patented NanoStat TM 53 Squalamine 53 patented BEMA 53 commercializing anti infective 53 small molecule glucokinase 53 Uvidem 53 OncoVEX GM CSF 53 MAXY G# 53 antiangiogenic agents 53 P#X# antagonist 53 ix Immtech ability 53 EOquin 53 Amplimexon 53 Fc engineered 53 IMC #B 53 Anticalin 53 OncoVEX 53 BXT # 53 GLPG# 53 DepoBupivacaine TM 53 clinically validated targets 53 UltiMAb TM 53 A3 adenosine receptor 53 carcinoid syndrome diabetes 53 Skinvisible receives 53 Targeted Chemotherapy 53 developing TB4 53 favorable pharmacokinetic profile 53 Kinase inhibitors 53 Synta scientists 53 Prodrug TAP technology 53 Litx 53 novel anticancer 53 ProLindac TM 53 Imec performs world 52 ADME properties 52 topical anti infective 52 patented DepoVax TM 52 product Abreva ® 52 MDRNA proprietary 52 Epothilones 52 Daclizumab 52 Antigen Express comprise immunotherapeutics 52 hepatitis C protease inhibitor 52 AERx iDMS 52 Vitamin D analogue 52 pimavanserin ACADIA 52 compound AEZS 52 6 sulfatase 52 GED aPC 52 IND submission 52 nanoviricide drug 52 Src inhibitors 52 ALN RSV program 52 infectious diseases autoimmune diseases 52 Relypsa 52 Sentient specializes 52 predictive biomarkers 52 tezampanel 52 mecamylamine hydrochloride 52 MVA BN R 52 Chrysalin r rusalatide acetate 52 fusion inhibitor 52 Phase IIa trials 52 LHRH receptor positive 52 CTLA4 Ig product 52 lomitapide 52 tezampanel NGX# 52 Nucleic Acid Detection Immunoassay 52 HCV nucleoside polymerase inhibitors 52 molecular entities NMEs 52 delta isoform 52 immatics 52 coronary stent merged 52 PD2i CA Cardiac Analyzer 52 tumor activated prodrug 52 drug conjugates 52 DermaVir Patch 52 product Abreva 52 Luteinizing Hormone Releasing Hormone 52 HCD# [002] 52 OvaRex 52 SonoLysis 52 potency selectivity 52 small molecule tyrosine 52 Delcath novel 52 renin inhibitor 52 migraine headaches neuropathic pain 52 HCV polymerase 52 CCR5 antagonist 52 telomerase inhibitor 52 TOCOSOL Paclitaxel 52 small molecule Hsp# 52 nicotinic alpha 7 52 Excellarate TM 52 HCV polymerase inhibitors 52 proteasome inhibitor 52 GLP toxicology studies 52 Dicer Substrate Technology 52 var arrMeta = 52 semi synthetic lipoglycopeptide 52 PD2i ® algorithm 52 preclinical studies Vion 52 noninvasive prenatal genetic 52 Cloretazine 52 Sangamo ZFP technology 52 var arrContent = 52 Tß4 52 Fleximer R 52 Adenosine Therapeutics 52 Array BioPharma Reports 52 biomimetics non 52 Cathepsin S 52 CFTR inhibitors 52 MET inhibitor 52 Aerosurf 52 XP #L 52 MOR# 52 OHR/AVR# 52 histone deacetylase HDAC inhibitors 52 concerning Zalicus 52 HGS ETR1 52 proprietary electrotherapeutic technology 52 Phase 2b clinical trials 52 Phase IIb clinical trials 52 compound tesamorelin 52 ularitide 52 VBL proprietary 52 Rosetta dependence 52 purinergic receptors P#X# 52 oral salmon calcitonin 52 TMC# [002] 52 POTELLIGENT ® 52 protein kinase inhibitor 52 website www.nyandcompany.com 52 DPX Survivac 52 indibulin 52 CRD5 52 chemical entities NCEs 52 immune modulating 52 small molecule PEGylation 52 AMPK activators 52 virus HCV protease inhibitor 52 scalable PLX PLacental 52 vivo potency 52 recombinant polyclonal antibody 52 anti botulism antibody 52 Stimuvax R 52 Xencor XmAb 52 tranilast 52 Locked Nucleic Acid 52 lixivaptan 52 R roscovitine 52 Relovair 52 pradefovir 52 selectively induce apoptosis 52 ABL inhibitor completing 52 proprietary synthetic peptides 52 epigenetic therapeutics 52 anticancer compounds 52 HYVISC ® treatment 52 Unigene nasal calcitonin 52 Hedgehog agonist 52 bioengineers novel 52 angiogenesis inhibit 52 candidate SILENOR TM 52 RELOVAIR ™ 52 epigenetic therapies 52 unproven preclinical 52 Anticalin ® 52 Provecta TM 52 Company TAIFUN R 52 selective estrogen receptor modulator 52 small molecule VR1 52 chemistry microbiology immunology 52 processing clai MORE 52 preclinical 52 proprietary HuCNS SC 52 AzaSite ISV 52 CTA# 52 registrational trial 52 investigational oral therapy 52 relapsed leukemia 52 HGS# 52 signal averaging electrocardiography 52 estradiol gel indicated 52 eye socket ruptured bladder 52 Micromet BiTE 52 unique PER.C6 ® 52 ESBA# 51 Drug Discovery AIDD 51 HuCAL PLATINUM ® CysDisplay 51 Plicera 51 Aegera Therapeutics 51 AVN# [001] 51 selective kinase inhibitor 51 Bioaccelerate compounds under 51 NASDAQ PANC biotechnology 51 TH# [003] 51 basal insulin analogue 51 precision op amps 51 FOLOTYN ® 51 novel RNAi therapeutics 51 eligen R technology 51 AFFiRiS 51 PLX STROKE targeting 51 Aurora kinase inhibitor 51 product Abreva R 51 MP4 molecule 51 ZK EPO 51 ISIS # 51 Asentar 51 patented DepoVax ™ 51 AAG KOS 51 Alequel ™ 51 vosaroxin 51 ICA # 51 Organ Regeneration Platform 51 selective receptor agonist 51 By SALLY SPAULDING 51 GlycoPEGylated hemostasis compounds 51 ASG 5ME 51 ulimorelin 51 Alzheimer disease cognitive dysfunction 51 SynCon ™ DNA 51 CB1 antagonists 51 Aquinox 51 Cetrorelix 51 BiTE 51 Regado 51 immunology oncology 51 AeroLEF R 51 Corgenix diagnostic products 51 pursue biocatalyst enabled 51 immunotherapeutic vaccine 51 Sopherion 51 Xanafide 51 Janis Joplin soundalike respiratory 51 TOCOSOL 51 potent antiproliferative 51 JAK3 51 Cobalamin 51 USHE groundbreaking pocket BLU 51 proprietary phage display 51 By Sara Faiwell 51 JAK2 inhibitors 51 monoclonal antibody therapeutics 51 Thiarabine 51 advanced polymer conjugate 51 Elevated triglycerides 51 FoldRx 51 Bigger Zino 51 RNAi therapeutic targeting PCSK9 51 patented Bioral R nanocochleate 51 SIRT1 activators 51 cyclophilin inhibitors 51 Tyrima 51 HyACT 51 proprietary BiTE antibody 51 KinomeScan 51 Angiotensin receptor blockers 51 JAK2 inhibitor 51 tPEMF tm 51 XOMA 3AB biodefense 51 signal detection CTSD 51 Ketotransdel 51 TLR Therapeutics 51 PNT# 51 SYGNIS 51 E2F Decoy 51 Presently DARA 51 endocrinology oncology 51 small molecule 51 Proxinium TM 51 Curaxins 51 PhaseBio 51 regenerative stem cell 51 Hepatitis C Virus HCV 51 intranasal formulation 51 Troxatyl 51 Kosan motilin agonist 51 Allovectin 7 51 regorafenib 51 TACI Ig 51 inhaled AAT 51 produces potent VLP 51 highly selective adenosine 51 X Excite 51 endothelin antagonist 51 favorable pharmacokinetic 51 Cytolin R 51 personalized immunotherapy 51 Hybridon 51 GKAs 51 entinostat 51 Idera delivers 51 MAXY alpha 51 ARIKACE ™ 51 inhaled formulation 51 Italy Novamont SPA 51 Christos Mantzoros 51 silico prediction 51 Insegia 51 HCV nucleotide polymerase inhibitor 51 microRNA biomarkers 51 PF # [002] 51 Zybrestat 51 castrate resistant prostate cancer 51 cholesteryl ester transfer 51 Cerimon 51 integrative pharmacology 51 JAK3 inhibitor 51 REG2 Regado 51 Antibody Drug Conjugate 51 neuroprotective properties 51 PS# [001] 51 sapacitabine 51 Medarex applies 51 Galenea 51 5 HT6 51 advanced biocompatible coatings 51 AMSC wholly owned 51 OXi# 51 recombinant factor VIIa 51 MorphoSys proprietary 51 NEUMUNE 51 proven DuraSite ® 51 developing ostarine selective 51 PicoP display technology 51 Menerba 51 TURNING INSIGHTS INTO HOPE 51 patented NanoStat ™ 51 VortiQa 51 Rosetta Genomics Nasdaq ROSG 51 oncology dermatology 51 Genius Glyder Stranded 51 Tyzeka Sebivo 51 EndoTAG 51 Xcellerated T Cells 51 Muraglitazar 51 ibudilast 51 RNA antagonists 51 Cephalon Oncology 51 Genz # 51 polymerase inhibitors 51 RNA antisense 50 Enhanze TM Technology 50 vaccine GRNVAC1 50 allosteric modulator 50 By CINDY BARKS 50 XL# XL# XL# 50 HIV integrase inhibitor 50 Evoltra ® 50 induced tumor regression 50 fesoterodine 50 RenaZorb 50 mGluR4 PAM 50 Flamel Medusa R 50 SNT MC# 50 DWS Trust 50 OpenArray ® 50 novel chimeric natriuretic 50 oncolytic viruses 50 Bicifadine 50 SARMs 50 farletuzumab 50 POWERSTACK TM MC# 50 Ceflatonin R 50 MAbs 50 VeraTag assays 50 CINOD 50 Staphylococcus aureus Immune Globulin 50 Bendavia 50 lymphoid tumors 50 thermal CPVT technology 50 CCR5 inhibitor 50 Catabasis 50 validating biomarkers 50 Ltd. TTI Telecom 50 proprietary hydrogel 50 Amgen discovers develops 50 By Beth Sneller 50 peptide therapeutics 50 Palifosfamide Zymafos TM 50 compound AEOL # 50 read Palintologist 50 staphylococcal vaccine 50 markets Testim ® 50 ABILIFY ® 50 NATIONAL ECONOMIC COUNCIL DIRECTOR 50 DepoCyt ® Abelcet ® 50 Aradigm Logo 50 immunosuppressant therapies 50 endosomal release 50 Taligen 50 approved incretin mimetic 50 XmAb# 50 eWorld Interactive eWorld 50 HuMax TF 50 benign proliferative disorders 50 gastrointestinal GI perforations 50 triphendiol 50 selective kinase inhibitors 50 Amgen Kyowa Hakko Kirin 50 Intarcia 50 BiTE R